Bruce Neal's Publications

About Bruce Neal's Publications

Executive Director, The George Institute for Global Health, Australia
  • Acute declines in eGFR during treatment with canagliflozin and its implications for clinical practice: insights from CREDENCE

    Diabetologia Date published:
  • Acute declines in eGFR during treatment with canagliflozin and its implications for clinical practice: insights from CREDENCE

    Diabetologia Date published:
  • Acute declines in eGFR during treatment with canagliflozin and its implications for clinical practice: insights from CREDENCE

    Diabetologia Date published:
  • Acute declines in eGFR during treatment with canagliflozin and its implications for clinical practice: insights from CREDENCE

    Diabetologia Date published:
  • Acute declines in eGFR during treatment with canagliflozin and its implications for clinical practice: insights from CREDENCE

    Diabetologia Date published:
  • Acute declines in eGFR during treatment with canagliflozin and its implications for clinical practice: insights from CREDENCE

    Diabetologia Date published:
  • Acute declines in eGFR during treatment with canagliflozin and its implications for clinical practice: insights from CREDENCE

    Diabetologia Date published:
  • Acute declines in eGFR during treatment with canagliflozin and its implications for clinical practice: insights from CREDENCE

    Diabetologia Date published:
  • Acute declines in eGFR during treatment with canagliflozin and its implications for clinical practice: insights from CREDENCE

    Diabetologia Date published:
  • Acute declines in eGFR during treatment with canagliflozin and its implications for clinical practice: insights from CREDENCE

    Diabetologia Date published:
  • Acute declines in eGFR during treatment with canagliflozin and its implications for clinical practice: insights from CREDENCE

    Diabetologia Date published:
  • Acute declines in eGFR during treatment with canagliflozin and its implications for clinical practice: insights from CREDENCE

    Diabetologia Date published:
  • Acute declines in eGFR during treatment with canagliflozin and its implications for clinical practice: insights from CREDENCE

    Diabetologia Date published:
  • Acute declines in eGFR during treatment with canagliflozin and its implications for clinical practice: insights from CREDENCE

    Diabetologia Date published:
  • Acute declines in eGFR during treatment with canagliflozin and its implications for clinical practice: insights from CREDENCE

    Diabetologia Date published:
  • Prospective associations of four nutrient profiles with weigh gain, overweight and obesity risk

    European Journal of Public Health Date published: